Reg4 protects against acinar cell necrosis in experimental pancreatitis

Gut

Volumn 60, Issue 6, 2011, Pages 820-828

  Hu, Guoyong ^a   Shen, Jiaqing ^b   Cheng, Li ^b   Guo, Chuanyong ^a   Xu, Anfu ^a   Wang, Feng ^b   Huang, Li ^a   Yang, Lijuan ^b   He, Miao ^c   Xiang, Di ^c   Zhu, Shunying ^c   Wu, Mingyuan ^c   Yu, Yan ^c   Han, Wei ^c   Wang, Xingpeng ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; ARGININE; CELL PROTEIN; CERULETIDE; DRUG VEHICLE; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; NEUTRALIZING ANTIBODY; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN REG4; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN REG4; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ACINAR CELL; ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL ISOLATION; CELL PROTECTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MIXTURE; DRUG TARGETING; EPITHELIUM; GENE EXPRESSION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MALE; METAPLASIA; MOUSE; NONHUMAN; PANCREAS EPITHELIUM; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TISSUE REGENERATION; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; UPREGULATION;

ANIMALS; ARGININE; BCL-X PROTEIN; CELL DEATH; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; LECTINS, C-TYPE; MALE; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; PANCREAS; PANCREATITIS, ACUTE NECROTIZING; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEINS; UP-REGULATION;

EID: 79955837437     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.215178     Document Type: Article

References (41)

1. Hartupee JC, Zhang H, Bonaldo MF, et al. Isolation and characterization of a cDNA encoding a novel member of the human regenerating protein family: Reg IV. Biochim Biophys Acta 2001;1518:287-93. (Pubitemid 32324196)
2. Kamarainen M, Heiskala K, Knuutila S, et al. RELP, a novel human REG-like protein with up-regulated expression in inflammatory and metaplastic gastrointestinal mucosa. Am J Pathol 2003;163:11-20. (Pubitemid 36759586)
3. Violette S, Festor E, Pandrea-Vasile I, et al. Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas. Int J Cancer 2003;103:185-93. (Pubitemid 35461510)
4. Oue N, Kuniyasu H, Noguchi T, et al. Serum concentration of Reg IV in patients with colorectal cancer: overexpression and high serum levels of Reg IV are associated with liver metastasis. Oncology 2007;72:371-80. (Pubitemid 351238152)
5. Oue N, Mitani Y, Aung PP, et al. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. J Pathol 2005;207:185-98. (Pubitemid 41404149)
6. Mitani Y, Oue N, Matsumura S, et al. Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy. Oncogene 2007;26:4383-93. (Pubitemid 47014457)
7. Zheng HC, Xu XY, Yu M, et al. The role of Reg IV gene and its encoding product in gastric carcinogenesis. Hum Pathol 2010;41:59-69.
8. Yamagishi H, Fukui H, Sekikawa A, et al. Expression profile of REG family proteins REG Ialpha and REG IV in advanced gastric cancer: comparison with mucin phenotype and prognostic markers. Mod Pathol 2009;22:906-13.
9. Tamura H, Ohtsuka M, Washiro M, et al. Reg IV expression and clinicopathologic features of gallbladder carcinoma. Hum Pathol 2009;40:1686-92.
10. Takehara A, Eguchi H, Ohigashi H, et al. Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4. Cancer Sci 2006;97:1191-7. (Pubitemid 44430644)
11. Takayama R, Nakagawa H, Sawaki A, et al. Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma. J Gastroenterol 2010;45:52-9.
12. Legoffic A, Calvo E, Cano C, et al. The reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic target. PLoS One 2009;4:e7495.
13. Ohara S, Oue N, Matsubara A, et al. Reg IV is an independent prognostic factor for relapse in patients with clinically localized prostate cancer. Cancer Sci 2008;99:1570-7.
14. Gu Z, Rubin MA, Yang Y, et al. Reg IV: a promising marker of hormone refractory metastatic prostate cancer. Clin Cancer Res 2005;11:2237-43. (Pubitemid 40490182)
15. Nanakin A, Fukui H, Fujii S, et al. Expression of the REG IV gene in ulcerative colitis. Lab Invest 2007;87:304-14. (Pubitemid 46353938)
16. Bishnupuri KS, Luo Q, Murmu N, et al. Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas. Gastroenterology 2006;130:137-49. (Pubitemid 43049844)
17. Rafa L, Dessein AF, Devisme L, et al. REG4 acts as a mitogenic, motility and pro-invasive factor for colon cancer cells. Int J Oncol 2010;36:689-98.
18. Li XH, Zheng Y, Zheng HC, et al. REG IV overexpression in an early stage of colorectal carcinogenesis: an immunohistochemical study. Histol Histopathol 2010;25:473-84.
19. Bishnupuri KS, Luo Q, Sainathan SK, et al. Reg IV regulates normal intestinal and colorectal cancer cell susceptibility to radiation-induced apoptosis. Gastroenterology 2010;138:616-26.
20. Eguchi H, Ishikawa O, Ohigashi H, et al. Serum REG4 level is a predictive biomarker for the response to preoperative chemoradiotherapy in patients with pancreatic cancer. Pancreas 2009;38:791-8.
21. Hu G, Shen J, Cheng L, et al. Purification of a bioactive recombinant human Reg IV expressed in Escherichia coli. Protein Expr Purif 2010;69:186-90.
22. Dawra R, Sharif R, Phillips P, et al. Development of a new mouse model of acute pancreatitis induced by administration of L-arginine. Am J Physiol Gastrointest Liver Physiol 2007;292:G1009-18.
23. Gironella M, Folch-Puy E, LeGoffic A, et al. Experimental acute pancreatitis in PAP/ HIP knock-out mice. Gut 2007;56:1091-7. (Pubitemid 47123239)
24. Gukovskaya AS, Gukovsky I, Zaninovic V, et al. Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J Clin Invest 1997;100:1853-62. (Pubitemid 27431345)
25. Mareninova OA, Sung KF, Hong P, et al. Cell death in pancreatitis: caspases protect from necrotizing pancreatitis. J Biol Chem 2006;281:3370-81. (Pubitemid 43845951)
26. Sung KF, Odinokova IV, Mareninova OA, et al. Prosurvival Bcl-2 proteins stabilize pancreatic mitochondria and protect against necrosis in experimental pancreatitis. Exp Cell Res 2009;315:1975-89.
27. Cao Y, Adhikari S, Clement MV, et al. Induction of apoptosis by crambene protects mice against acute pancreatitis via anti-inflammatory pathways. Am J Pathol 2007;170:1521-34. (Pubitemid 47339298)
28. Toma H, Winston J, Micci MA, et al. Nerve growth factor expression is up-regulated in the rat model of L-arginine-induced acute pancreatitis. Gastroenterology 2000;119:1373-81.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9. (Pubitemid 17064313)
30. Warzecha Z, Dembinski A, Konturek PC, et al. Epidermal growth factor protects against pancreatic damage in cerulein-induced pancreatitis. Digestion 1999;60:314-23. (Pubitemid 29292227)
31. Dembinski A, Warzecha Z, Konturek PC, et al. Epidermal growth factor accelerates pancreatic recovery after caerulein-induced pancreatitis. Eur J Pharmacol 2000;398:159-68. (Pubitemid 30336689)
32. Wang X, McCullough KD, Franke TF, et al. Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J Biol Chem 2000;275:14624-31. (Pubitemid 30339753)
33. Leist M, Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2001;2:589-98. (Pubitemid 33674010)
34. Proskuryakov SY, Konoplyannikov AG, Gabai VL. Necrosis: a specific form of programmed cell death? Exp Cell Res 2003;283:1-16.
35. Edinger AL, Thompson CB. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 2004;16:663-9. (Pubitemid 39463117)
36. Bhatia M. Apoptosis versus necrosis in acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2004;286:G189-96.
37. Zhang H, Kandil E, Lin YY, et al. Targeted inhibition of gene expression of pancreatitis-associated proteins exacerbates the severity of acute pancreatitis in rats. Scand J Gastroenterol 2004;39:870-81. (Pubitemid 39215459)
38. Lin YY, Viterbo D, Mueller CM, et al. Small-interference RNA gene knockdown of pancreatitis-associated proteins in rat acute pancreatitis. Pancreas 2008;36:402-10. (Pubitemid 351591583)
39. Viterbo D, Callender GE, DiMaio T, et al. Administration of anti-Reg I and anti-PAPII antibodies worsens pancreatitis. JOP 2009;10:15-23.
40. Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 2006;20:197-209.
41. Bhatia M, Brady M, Shokuhi S, et al. Inflammatory mediators in acute pancreatitis. J Pathol 2000;190:117-25. (Pubitemid 30082483)